(Allergan plc)

	AGN latest price $151.5899 (0.45%) ($150.7517 - $153.4460) on Mon. May. 14, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.98% (three month average)
RSI	46
Latest Price	$151.5899(0.45%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 1% a day on average for past five trading days.
Weekly Trend	AGN declines -2.4% a week on average for past two weeks.
Market Behavior	Normal for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(48%)    XBI(46%)    ARKG(44%)    IVE(44%)
Factors Impacting AGN price	AGN will decline at least -0.99% in a week (0% probabilities).   VIXM(-28%)    TLT(-21%)    UUP(-19%)    DIA(-9%)    GDXJ(-6%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.99% (StdDev 1.98%)
Hourly BBV	0 ()
Intraday Trend	0.5%

Resistance Level	$151.8
5 Day Moving Average	$147.31(2.91%)
10 Day Moving Average	$147.16(3.01%)
20 Day Moving Average	$151.8(-0.14%)
To recent high	-8.6%
To recent low	7.3%
Market Cap	$49.979b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed